1 194

Cited 32 times in

Development of an injectable composite as a carrier for growth factor-enhanced periodontal regeneration.

Authors
 Samuel Herberg  ;  Michael Siedler  ;  Susanne Pippig  ;  Andreas Schuetz  ;  Carola Dony  ;  Chong-Kwan Kim  ;  Ulf M. E. Wikesjo 
Citation
 JOURNAL OF CLINICAL PERIODONTOLOGY, Vol.35(11) : 976-984, 2008 
Journal Title
 JOURNAL OF CLINICAL PERIODONTOLOGY 
ISSN
 0303-6979 
Issue Date
2008
MeSH
Animals ; Biocompatible Materials/administration & dosage ; Blood Coagulation/drug effects ; Bone Regeneration/drug effects ; Dental Cementum/drug effects ; Dogs ; Drug Carriers/administration & dosage* ; Drug Carriers/chemistry ; Drug Carriers/metabolism ; Growth Differentiation Factor 5/administration & dosage* ; Humans ; Injections ; Lactic Acid/administration & dosage* ; Lactic Acid/chemistry ; Lactic Acid/metabolism ; Periodontal Diseases/surgery ; Periodontal Ligament/drug effects ; Periodontium/drug effects* ; Polyglycolic Acid/administration & dosage* ; Polyglycolic Acid/chemistry ; Polyglycolic Acid/metabolism ; Polylactic Acid-Polyglycolic Acid Copolymer ; Porosity ; Recombinant Proteins/administration & dosage ; Regeneration/drug effects* ; Wound Healing/drug effects
Keywords
bioresorbable ; blood clot ; in situ setting ; minimally invasive ; periodontal regeneration ; PLGA ; rhGDF‐5 ; space providing
Abstract
AIM: Biomaterials are often applied in periodontal therapy; however, not always well adapted for tissue regeneration. The objective of this study was to evaluate the physico-chemical properties and biocompatibility of an injectable, in situ setting composite for growth factor-enhanced periodontal regeneration. MATERIAL AND METHODS: The composite constitutes bioresorbable poly(lactic-co-glycolic acid) (PLGA) and additives forming in situ a matrix designed as a carrier for recombinant human growth/differentiation factor-5 (rhGDF-5). In vitro characterization included the porosity, biointeraction, biodegradation, injectability, and biological activity of released rhGDF-5. Biocompatibility was compared with granular beta-tricalcium phosphate and an absorbable collagen sponge using a canine periodontal defect model. RESULTS: The PLGA composite showed a highly porous (500-1000 mum) space-providing structure. It effectively induced coagulation exhibiting an intimate interaction with the fibrin clot. The biphasic biodegradation was complete within 4 weeks. The composite was conveniently injectable (90.4+/-3.6 N) for ease of use. It exhibited a sustained rhGDF-5 release over 4 weeks (40.8%) after initial burst (3.4%) detected by ALP activity. Sites receiving the composite showed limited, if any, residuals and had no appreciable negative effect on periodontal wound healing. There were no noteworthy inflammatory lesions in sites receiving the PLGA composite. CONCLUSION: Characteristics of the PLGA composite makes it an attractive matrix to support native wound healing and rhGDF-5-enhanced periodontal regeneration.
Full Text
http://onlinelibrary.wiley.com/doi/10.1111/j.1600-051X.2008.01323.x/abstract
DOI
10.1111/j.1600-051X.2008.01323.x
Appears in Collections:
2. College of Dentistry (치과대학) > Dept. of Periodontics (치주과학교실) > 1. Journal Papers
Yonsei Authors
Kim, Chong Kwan(김종관)
URI
https://ir.ymlib.yonsei.ac.kr/handle/22282913/107976
사서에게 알리기
  feedback

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Browse